Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine
Lawrence Ku(Center for Drug Evaluation and Research), Chiara Melloni, Huali Wu(Duke University), Jeffrey T. Guptill(Duke University), Kevin D. Hill(Duke University), Rachel G. Greenberg(Duke University), Daniel González(University of North Carolina at Chapel Hill), Christoph P. Hornik(Duke University), Nan Zheng(Capital Medical University), Alysha Berezny(Duke University), Wenlei Jiang(United States Food and Drug Administration), Michael Cohen‐Wolkowiez(Duke University)
Cited by 10
Related Papers
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
Rapid transport of deformation-tuned nanoparticles across biological hydrogels and cellular barriers
|Nature Communications|2018|296